Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-24 @ 7:13 PM
NCT ID:
NCT00166803
Eligibility Criteria:
Inclusion Criteria:
1. Type II DM patients who are aged 50 to 80 year-old with HbA1c between 7.0 to 10.0 %
2. Under ≤ 2 kinds of anti-diabetic drugs.
Exclusion Criteria:
1. Insulin use
2. Patients who receive any PPARγ agonist in recent one year.
3. Women of child-bearing potential are excluded (i.e. menopausal women or post-hysterectomy women are included in this study) due to radiation exposure in this study.
4. Significant concomitant disease such as active infection, malignancy, hepatic or renal dysfunction at the time of enrollment (i.e. T-Bil \> 3 mg/dl，ALT \> 2.5 times the upper limit of normal range and Creatinine \> 3 mg/dl in our hospital).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT00166803
Study Brief:
Protocol Section:
NCT00166803